SMAD5 and diffuse large B-cell lymphoma: Both studies are in line with a previous report demonstrating that escaping from TGF-β-SMAD5-mediated growth inhibition through microRNA-155-mediated inhibition of SMAD5 is critical to relapse of DLBCL [415, 416].